Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. hVIVO Share Price
  4. hVIVO Share Regulatory News
  5. Open Orphan

Pin to quick pickshVIVO Regulatory News (HVO)

hVIVO Information

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes
Get Live Data
8.85    0.45 (5.36%)
Bid:
8.70
Ask:
9.00
Spread: 0.30 (3.448%)
Market Cap: £60.92m
HVO Live PriceLast checked at - London Stock Exchange

Intraday hVIVO Share Chart

Open Orphan

15 Jan 2020 17:30

RNS Number : 9383Z
FTSE Russell
15 January 2020
 

 

 

 

 

Open Orphan (UK): Merger with Hvivo (UK)Changes in FTSE UK Index Series

15 January 2020

Subject to the completion of the merger between Open Orphan (UK, constituent) and Hvivo (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

20 January 2020

 

* The number of shares is based on the merger terms of 2.47 new Open Orphan shares for every Hvivo share held.

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSSFWFIIESSEIF
123456789
Date   Source Headline
3rd Feb 20257:00 amRNSRSV contract signed with Inhalon Biopharma
31st Jan 20251:24 pmRNSHolding(s) in Company
31st Jan 20257:00 amRNSHolding(s) in Company
29th Jan 20257:01 amRNSAcquisition: two Clinical Research Units from CRS
29th Jan 20257:00 amRNSTrading update
27th Jan 20257:00 amRNSLOI signed for Phase 3 Whooping Cough trial
21st Jan 20257:00 amRNS£3.2m hLAB project
14th Jan 20257:00 amRNSHolding(s) in Company
13th Jan 20257:00 amRNS-RhMPV challenge model update
10th Dec 20247:00 amRNS£11.5m RSV contract and notice of trading update
19th Nov 20247:00 amRNSHolding(s) in Company
6th Nov 20247:00 amRNSHolding(s) in Company
11th Oct 20247:00 amRNSLong Term Incentive Plan/ PDMR Notification
24th Sep 20247:00 amRNSHolding(s) in Company
17th Sep 20247:00 amRNSHolding(s) in Company
13th Sep 20247:00 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSInterim results
5th Sep 20247:00 amRNSHolding(s) in Company
20th Aug 20247:00 amRNSNotice of results
6th Aug 20243:07 pmRNSHolding(s) in Company
5th Aug 20247:00 amRNSEuronext cancellation
24th Jul 20241:55 pmRNSHolding(s) in Company
23rd Jul 20242:48 pmRNSDirector/PDMR Shareholding
17th Jul 20247:01 amRNSHolding(s) in Company
17th Jul 20247:00 amRNSTrading update
8th Jul 20247:00 amRNSHolding(s) in Company
3rd Jul 20242:48 pmRNSHolding(s) in Company
2nd Jul 20247:02 amRNSChange of registered address
2nd Jul 20247:01 amRNSCapital Markets Day & Notice of trading update
2nd Jul 20247:00 amRNSInfluenza 2b field study contract
3rd Jun 20247:00 amRNS£2.5m contract for Omicron characterisation study
13th May 20241:02 pmRNSResult of AGM
15th Apr 20247:00 amRNSAnnual Report & Notice of AGM
9th Apr 20247:09 amRNSFinal results
27th Mar 20247:00 amRNSNotice of Results
22nd Mar 20243:03 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSLong Term Incentive Plan / PDMR Notification
14th Feb 20241:14 pmRNSResult of Secondary Placing
14th Feb 20247:00 amRNSProposed Secondary Placing of Ordinary Shares
2nd Feb 202412:44 pmRNSHolding(s) in Company
30th Jan 20247:00 amRNSTrading update
8th Jan 20247:00 amRNSBroker change
2nd Jan 20247:00 amRNS£6.3m HRV contract signed with biotech client
13th Dec 20237:00 amRNS£16.8m RSV contract & Trading ahead of guidance
5th Oct 20237:00 amRNSPositive results from flu human challenge study
12th Sep 20237:00 amRNSInterim results
1st Sep 20237:00 amRNSExercise of Warrants
29th Aug 20237:00 amRNSPlans for a new larger state-of-the-art facility
24th Aug 20237:00 amRNSNotice of Results
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
GROW
Molten Ventures
LSE
-1.50%
SST
Scottish Oriental Smaller Companies Trust
LSE
-0.74%
SJG
Schroder Japan
LSE
-0.27%
WAND.GB.PL
WAND.GB.PL
AQSE
0.00%
JII
JPMorgan Indian
LSE
0.00%
Trending
AVCT
Avacta Group
LSE
2.14%
PPP
Pennpetro Energy
LSE
0.00%
ITM
Itm Power
LSE
-10.85%
ALRT
Defence Holdings
LSE
19.05%
GST
GSTechnologies
LSE
8.11%